Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
(+)-Vincristine
Acute Leukemia
SWOG Cancer Research NetworkP2/3BB (71)
Adriamycin
Her2-Receptor Negative Breast Cancer
George Washington UniversityP4BB (70)
Alpelisib
Breast Cancer
M.D. Anderson Cancer CenterP4BB (70)
Apixaban
Stroke Disorder
Columbia UniversityP4BB (70)
Atorvastatin
Stroke Disorder
Duan ChuanzhiP4BB (70)
Calcium Hydroxide
Chronic Apical Periodontitis
Ain Shams UniversityP4BB (70)
Carbidopa
Parkinson Disease
Tanta UniversityP4BB (70)
Carvedilol
Cardiomyopathy
Post Graduate Institute of Medical Education and Research, ChandigarhP4BB (70)
Carvedilol
Hepatocellular Carcinoma
Tongji HospitalP4BB (70)
Carvedilol
Esophageal Varices With Bleeding
West China HospitalP4BB (70)
Cerebrolysin
Ischemic Stroke
University Medical Centre LjubljanaP4BB (70)
Cilostazol
Stroke Disorder
Northern California Institute of Research and EducationP4BB (70)
Cis-Diamminedichloroplatinum Ii
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P4BB (70)
Citalopram
Cognitive Disorder
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoP4BB (70)
Clonazepam
Epilepsy
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezP4BB (70)
Coagulation Factor Viia
Hemophilia B
American Thrombosis and Hemostasis NetworkP4BB (70)
Degarelix
Prostate Cancer
BayerP4BB (70)
Dexasone
Adult Acute Lymphoblastic Leukemia
Shanxi Bethune HospitalP4BB (70)
Dexketoprofen
Migraine Disorder
Suleyman Demirel UniversityP4BB (70)
Diazepam
Focal Epilepsy
University of CincinnatiP4BB (70)
Diphenhydramine
Plasma Cell Myeloma
SCRI Development Innovations, LLCP4BB (70)
Duloxetine
Neuralgia
Aristotle University Of ThessalonikiP4BB (70)
Epirubicin
Breast Neoplasm
Universitas AirlanggaP4BB (70)
Epirubicin
Hepatocellular Carcinoma
Fudan UniversityP4BB (70)
Fampridine
Multiple Sclerosis
MGH Institute of Health ProfessionsP4BB (70)
Showing 2501 to 2525 of 42,285 assets
PreviousPage 101 of 1692Next